Evidence map›Paper›PMID 40531323›Full record

SynthesisSchmerz (Berlin, Germany)2026

[Education for medication overuse headache : Results of a systematic literature review].

Hans-Christoph Diener, M Graf, H Löhr, P Kropp

Abstract readSystematic ReviewEnglish Abstract
In one paragraph

Synthesis in Schmerz (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hans-Christoph DienerAbteilung für Neuroepidemiologie, Institut für Medizinische Informatik, Biometrie und Epidemiologie (IMIBE), Universität Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Deutschland. hans.diener@uk-essen.de.
M GrafLundbeck GmbH, Hamburg, Deutschland.
H LöhrLundbeck GmbH, Hamburg, Deutschland.
P KroppInstitut für Medizinische Psychologie und Medizinische Soziologie, Universitätsmedizin Rostock, Rostock, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedication overuse headache (MOH) is often found in patients with chronic migraine as a result of worsening migraine accompanied by increasing amounts of acute medications. MOH is a relevant problem in clinical practice and the current German guideline on MOH recommends educational intervention to guide patients to reduce acute medication use.

objectivesThe aim was to investigate published approaches for education in MO (medication overuse) and MOH.

methodsA systematic literature search was conducted in PubMed. Publications were included in which details for education for the prevention and treatment in MO or MOH were described. The educational approaches were analyzed thematically.

resultsTwelve publications were included in this analysis. The described educational measures were effective in reducing or preventing MO or MOH. The educational content was heterogeneous, but some common topics were included in most of the educational approaches. These can be categorized in "education on the OH or MOH concept", "risk factors" and "treatment options". In few publications, additional topics related to "agreement on treatment" were mentioned.

conclusionEducation is effective in patients with medication overuse or medication overuse headache, but approaches differ. The overview presented here can be used as a basis to develop a structured educational approach for MOH.

Indexed as

AnalgesicsHeadache Disorders, SecondaryPatient Education as TopicGermanyHumansMigraine DisordersRisk FactorsAnalgesicsEducationHeadacheMedication overuseMedication overuse headacheMigraine

Identifiers

PMID40531323
PMCPMC13597559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.